drugset / Trial / NCT00690807

A Phase 2 Study of PH-10 for the Treatment of Atopic Dermatitis

NCT00690807

Phase 2 Completed 30 enrolled Provectus Pharmaceuticals
NaSingle-groupOpen-labelTreatment

Summary

PH-10 is a formulation of rose bengal disodium (RB) for topical administration to the skin. PH-10 is capable of undergoing photochemical reactions when activated by ambient light. This phase 2 study will assess whether topical PH-10 applied once daily to mild, moderate or severe areas of atopic dermatitis (including atopic eczema) may ameliorate inflammation of the skin when activated by ambient light.

Timeline

Start
2008-06
Primary completion
2009-08
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject rose bengal disodium Unknown Topical

Indications